Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation-Reference-Cited by-同舟云学术

Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation

Published:2014-09 Issue:9 Volume:24 Page:427-435
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Tapirdamaz Özlem,Hesselink Dennis A.,el Bouazzaoui Samira,Azimpour Mohammad,Hansen Bettina,van der Laan Luc J.W.,Polak Wojciech G.,Kwekkeboom Jaap,van Schaik Ron H.N.,van Gelder Teun,Metselaar Herold J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference47 articles.

1. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.;Dunn;Drugs,2001

2. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.;Spencer;Drugs,1997

3. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.;Staatz;Clin Pharmacokinet,2004

4. .Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.;Quteineh;Basic Clin Pharmacol Toxicol,2008

5. .Molecular and physical mechanisms of first-pass extraction.;Hall;Drug Metab Dispos,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation;Frontiers in Pharmacology;2024-01-08

2. Three-year results of renal function in liver transplant recipients on low-dose sirolimus and tacrolimus: a multicenter, randomized, controlled trial;Liver Transplantation;2023-01-03

3. Lack of Relationship Between Renal Function and Genetic Variants of CYP3A4, CYP3A5, MDR1, MRP2, UGT1A9, UGT1A8, and UGT2B7 in Patients After Liver Transplantation in a 2-Year Follow-up;Transplantation Proceedings;2020-10

4. Translational medical research and liver transplantation: systematic review;Translational Gastroenterology and Hepatology;2018-11

5. Effect of CYP3A5*1 expression on tacrolimus required dose after liver transplantation: A systematic review and meta-analysis;Clinical Transplantation;2018-06-21